|
Corporate Profile: Cynvec
Summary: |
Cynvec is focused on the development of the company's proprietary oncolytic sindbis viral vector for the treatment of cancer that overexpress the laminin receptor.
|
Address (HQ): |
245 Park Avenue
39th Floor
New York, NY 10167 |
Phone #'s (HQ): |
Main |
not known |
Human
Resources |
not known |
Investor
Relations |
not known |
Fax #'s (HQ): |
Main |
not known |
Human
Resources |
not known |
Investor
Relations |
not known |
Financial
information: |
not known |
Internet
job postings: |
not known |
Number
of employees: |
not known |
Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
Filed United States patent applications: |
Filed U.S. patent applications: 2001-present: patent
link. |
Publications on PubMed: |
Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|